SEC Form 4 · accession 0001209191-18-049645
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — Chief Medical Officer
Period of report
Aug 31, 2018
Accepted (ET)
Sep 5, 2018 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2018 | M | 1,800 | $5.95 | A | 149,269 | D | |
| Common Stock | Aug 31, 2018 | M | 5,000 | $14.575 | A | 154,269 | D | |
| Common StockF1 | Sep 4, 2018 | F | 994 | $61.05 | D | 153,275 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $5.95 | Aug 31, 2018 | M | 1,800 | D | — | Jun 27, 2022 | Common Stock | 1,800 | 0 | D |
| Stock Option (Right to Buy)F2 | $14.575 | Aug 31, 2018 | M | 5,000 | D | — | Mar 19, 2024 | Common Stock | 5,000 | 11,355 | D |
Explanation of responses
- F1Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- F2Fully vested.